Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s displayed ClinicalTrials.gov revision/version number has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:31:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added revision v3.5.2 to the history and removed revision v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:09:07.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added to the history and Revision: v3.4.3 was removed from the history.
    Difference
    0.0%
    Check dated 2026-03-18T21:54:42.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision history now includes Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:26:40.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Added References and Study Status sections and updated the record to Revision v3.4.2 on 2026-02-05, while removing the old government-funding notice and Revision v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:53:04.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page and updated the revision history to v3.4.1, removing the previous v3.4.0 entry.
    Difference
    0.3%
    Check dated 2026-02-04T05:58:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.